Emkay has released a report pointing out that the rupee-led fears which have led to under-performance of Pharma stocks are overblown and that this is an opportunity for investors to buy high-quality stocks
12 Top Quality Mid-Cap Winner Stocks For NAMO’s India 2.0
R Sreesankar of Prabhudas Lilladhar has issued a research report stating that the Nifty is likely to head to 9000 in the next 18 to 24 months. He has recommended 12 top-quality mid-cap stocks and a few large-cap stocks for purchase
What Is The Impact Of Rupee Appreciation On Pharma & InfoTech Stocks & Should We Buy Them? Daljeet Kohli
The appreciation in the value of the INR vis-à-vis the USD has caused Pharma & InfoTech stocks to under-perform the Index. Daljeet Kohli explains the extent of the impact and offers valuable advice on what investors should do
33 Best Mid-Cap Stocks To Buy Now: Axis Capital
Axis Capital has conducted an in-depth review of 33 top-quality mid-cap stocks which are quoting at reasonable valuations and which have great potential
Anish Jhaveri’s Prediction For MRPL Comes True – 3 Years Later
Today, when MRPL surged 19% intra-day, on the back of excellent Q4FY14 results, Anish Jhaveri of Antique Stock Broking heaved a huge sigh of relief. A prediction that he had made exactly 3 years ago finally came true
Dolly Khanna Rakes In Big Bucks In NAMO Rally
Dolly Khanna, our favourite stock wizard with a magic wand, has raked in big bucks with her splendid selection of stocks. Each of the stocks still looks good for the future as well
Tata Power Delivers On Rajen Shah’s Promise Of 25% Gain. Now Daljeet Kohli Promises More Gains
Rajen Shah of Angel Broking has lived up to his promise that Tata Power would provide a 25% gain. The best part is that Daljeet Kohli has promised more gains from the stock
Dolat Capital’s Top Sectors & Stocks For NAMO’s India 2.0
Dolat Capital has issued a report stating that there will be a structural re rating for India and have picked sectors and stocks that will benefit from that
Pharma & InfoTech Stocks Plunge In NAMO Rally (Which Means We Have To Buy Them)
Top-quality Pharma & Info Tech stocks have under-performed the rest of the market. Is there an opportunity here to be a contrarian and grab the stocks?
Daljeet Kohli Recommends Best Stocks & Sectors To Benefit From NAMO’s India 2.0
Daljeet Kohli of IndiaNivesh has issued a comprehensive report in which he has dealt with the strenghts & weaknesses of various stocks and sectors and their respective valuations in the context of NAMO’s India 2.0
Recent Comments